Syndecan 4-c-ros oncogene 1 fusion as a mechanism of acquired resistance in epidermal growth factor receptor mutant lung adenocarcinoma

by You-Cai Zhu, Chun-Wei Xu, Qu-Xia Zhang, Wen-Xian Wang, Lei Lei, Wu Zhuang, Peng Lyu
Published 2019-12-01

Molecular Characteristics and Clinical Outcomes of EGFR Exon 19 C-Helix Deletion in Non–Small Cell Lung Cancer and Response to EGFR TKIs

by Chun-wei Xu, Lei Lei, Wen-xian Wang, Li Lin, You-cai Zhu, Hong Wang, Li-yun Miao, Li-ping Wang, Wu Zhuang, Mei-yu Fang, Tang-feng Lv, Yong Song
Published 2020-09-01

Real‐world efficacy and potential mechanism of resistance of icotinib in Asian advanced non‐small cell lung cancer with EGFR uncommon mutations: A multi‐center study

by Lei Lei, Wen‐xian Wang, You‐cai Zhu, Jin‐luan Li, Yong Fang, Hong Wang, Wu Zhuang, Yin‐bin Zhang, Li‐ping Wang, Mei‐yu Fang, Chun‐wei Xu, Xiao‐jia Wang, Tang‐feng Lv, Yong Song
Published 2020-01-01